<DOC>
	<DOCNO>NCT00613860</DOCNO>
	<brief_summary>Patients heterogenous emphysema benefit endoscopic lung volume reduction . Until technique limit one lobe . In case collateral ventilation patient show improvement . Between upper middle lobe exist high collateral flow . The trial examine hypothesis , sequential ELVR help especially patient , benefit lobar exclusion .</brief_summary>
	<brief_title>Sequential Endoscopic Lung Volume Reduction</brief_title>
	<detailed_description>Patients heterogenous emphysema undergo ELVR , target lobe upper lobe right . After 6 week middle lobe block . Follow-up period 6 month Primary end point : FEV 1 , 6-Minute walk test Secondary endpoint . Safety , Symptom score Number patient plan 30</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Heterogenous emphysema FEV1 &lt; 45 % RV &gt; 150 % TLC &gt; 100 % TLCO &lt; 40 % Homogeneous emphysema Pregnancy PCO2 &gt; 50 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Endoscopic lung volume reduction , heterogeneous emphysema , interventional bronchoscopy</keyword>
</DOC>